629 filings
Page 5 of 32
DEFA14A
cr2gw46b
17 Jun 21
Additional proxy soliciting materials
4:38pm
8-K
tzzsoufpl4dohvq1f
16 Jun 21
United Therapeutics Announces Fda Acceptance
6:00am
8-K
pej0q
7 Jun 21
Other Events
6:01am
8-K
enzl 2746bj
3 Jun 21
United Therapeutics Announces First Patient Enrolled In Phase 3 Teton Study of Tyvaso In Patients with Idiopathic Pulmonary Fibrosis
6:00am
SD
x6kvexwtc7bet erh4
1 Jun 21
Conflict minerals disclosure
4:30pm
8-K
gtgkujyr5 nq8x8o4
5 May 21
United Therapeutics Corporation Reports First Quarter 2021 Financial Results
6:17am
DEFA14A
i408jet
29 Apr 21
Additional proxy soliciting materials
4:30pm
DEFA14A
upniopj7 ums7ea
29 Apr 21
Additional proxy soliciting materials
6:07am
8-K
rpk52lx
19 Apr 21
United Therapeutics Announces Submission of Tyvaso Dpi™ New Drug Application to Fda
6:02am
8-K
2mtb 40drzmod
1 Apr 21
Other Events
6:03am
8-K
3hddp516ncdnmc0hz
3 Mar 21
Other Events
6:02am
8-K
pgssbg1 mqpxikho
24 Feb 21
United Therapeutics Corporation Reports Fourth Quarter
6:09am
8-K
7vnldgpz7s9nz9fqw
10 Feb 21
United Therapeutics Announces Commercial Launch
6:01am
8-K
bxzhlgklrnf
5 Feb 21
Amendments to Articles of Incorporation or Bylaws
6:05am
8-K
a49t16q2uss i71
28 Jan 21
United Therapeutics Announces Breeze Study of
6:01am
8-K
4vwumizvix 1u
22 Jan 21
Other Events
6:01am
8-K
ky4v2
13 Jan 21
Other Events
5:01pm